I am a
Home I AM A Search Login

Papers of the Week


January 27, 2023


Molecules


http://www.ncbi.nlm.nih.gov/pubmed/36615298?dopt=Abstract


28


1

Bioactive Compound-Based Formulations: New Perspectives for the Management of Orofacial Pain.

Authors

Crescente G, Minervini G, Spagnuolo C, Moccia S
Molecules. 2022 Dec 23; 28(1).
PMID: 36615298.

Abstract

The management of orofacial pain to alleviate the quality of life of affected patients is becoming increasingly challenging for scientific research and healthcare professionals. From this perspective, in addition to conventional therapies, new alternatives are being sought, increasingly looking at the use of both natural and synthetic products. L. represents an interesting source of bioactive compounds, including non-psychoactive cannabinoids, flavonoids, and terpenes, many of which are effective in improving pain intensity. Here, we aim to analyze the possible mechanisms of action of the bioactive natural and synthetic hemp-derived compounds responsible for the modulatory effects on pain-related pathways. The ability of these compounds to act on multiple mechanisms through a synergistic effect, reducing both the release of inflammatory mediators and regulating the response of the endocannabinoid system, makes them interesting agents for alternative formulations to be used in orofacial pain.